These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. Francisco V; Ruiz-Fernández C; Pino J; Mera A; González-Gay MA; Gómez R; Lago F; Mobasheri A; Gualillo O Biochem Pharmacol; 2019 Jul; 165():196-206. PubMed ID: 30910694 [TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome, inflammation and atherosclerosis - the role of adipokines in health and in systemic inflammatory rheumatic diseases. Santos MJ; Fonseca JE Acta Reumatol Port; 2009; 34(4):590-8. PubMed ID: 20852572 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and systemic lupus erythematosus: the connection. Mok CC Expert Rev Clin Immunol; 2019 Jul; 15(7):765-775. PubMed ID: 31094570 [No Abstract] [Full Text] [Related]
7. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Gremese E; Ferraccioli G Autoimmun Rev; 2011 Aug; 10(10):582-9. PubMed ID: 21539940 [TBL] [Abstract][Full Text] [Related]
8. Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases. Scotece M; Conde J; Gómez R; López V; Pino J; González A; Lago F; Gómez-Reino JJ; Gualillo O Mediators Inflamm; 2012; 2012():125458. PubMed ID: 22910888 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. Wang Y; Yu Q; Chen Y; Cao F Curr Pharm Des; 2013; 19(27):4799-805. PubMed ID: 23323622 [TBL] [Abstract][Full Text] [Related]
10. Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis. Miao J; Zhu P Curr Rheumatol Rep; 2018 Apr; 20(5):30. PubMed ID: 29663162 [TBL] [Abstract][Full Text] [Related]
11. [Autoimmune Rheumatic Diseases - Problems of Immunopathology and Personalized Treatment]. Nasonov EL; Aleksandrova EN; Novikov AA Vestn Ross Akad Med Nauk; 2015; (2):169-82. PubMed ID: 26234089 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-mediated immune regulation in rheumatic diseases. Lam IKY; Chow JX; Lau CS; Chan VSF Cancer Lett; 2018 Sep; 431():201-212. PubMed ID: 29859876 [TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review. Liu B; Shu S; Kenny TP; Chang C; Leung PS Clin Rev Allergy Immunol; 2014 Oct; 47(2):244-57. PubMed ID: 25146442 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project. Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA; Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345 [TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. Santilli F; D'Ardes D; Guagnano MT; Davi G Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503 [TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings. Zinger H; Sherer Y; Shoenfeld Y Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of hypertension in autoimmune rheumatic diseases. Taylor EB; Wolf VL; Dent E; Ryan MJ Br J Pharmacol; 2019 Jun; 176(12):1897-1913. PubMed ID: 30714094 [TBL] [Abstract][Full Text] [Related]
18. Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis. Ferraccioli G; Gremese E Swiss Med Wkly; 2011; 141():w13211. PubMed ID: 21618146 [TBL] [Abstract][Full Text] [Related]